GENTILI, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 1.479
EU - Europa 639
AS - Asia 346
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 2.468
Nazione #
US - Stati Uniti d'America 1.427
CN - Cina 305
DE - Germania 217
IT - Italia 102
UA - Ucraina 65
SE - Svezia 64
CA - Canada 52
GB - Regno Unito 51
FI - Finlandia 43
CZ - Repubblica Ceca 21
SG - Singapore 18
PL - Polonia 15
FR - Francia 14
IE - Irlanda 14
BE - Belgio 11
NL - Olanda 9
JP - Giappone 7
IR - Iran 6
RO - Romania 6
IN - India 3
TR - Turchia 3
ES - Italia 2
EU - Europa 2
RU - Federazione Russa 2
VN - Vietnam 2
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
EE - Estonia 1
MN - Mongolia 1
PE - Perù 1
TH - Thailandia 1
Totale 2.468
Città #
Woodbridge 186
Jacksonville 169
Chandler 166
Ann Arbor 125
Fairfield 110
Wilmington 77
Nanjing 73
Ashburn 63
Dearborn 50
Houston 50
Düsseldorf 39
Seattle 37
Toronto 36
Beijing 33
Cambridge 31
San Mateo 26
Kunming 21
Lawrence 21
Princeton 21
Helsinki 20
Boardman 19
Shanghai 18
Ogden 17
Brno 16
Columbus 16
Lachine 16
Kraków 15
Nanchang 15
Dublin 14
Tianjin 14
Falls Church 13
Singapore 13
Brussels 11
Shenyang 11
Venezia 11
Hangzhou 10
Changsha 9
Milan 9
Nürnberg 9
Los Angeles 8
San Diego 8
Guangzhou 7
Jiaxing 7
Taizhou 7
Wuhan 7
Camerino 6
Dronten 6
Philadelphia 6
Centro 5
Hebei 5
Hefei 5
London 5
Old Bridge 5
Redwood City 5
Venice 5
Bremen 4
Horia 4
Munich 4
New York 4
Olomouc 4
Fuzhou 3
Hanover 3
Jinan 3
Kocaeli 3
Lanzhou 3
Leawood 3
Ningbo 3
Tampere 3
Zhengzhou 3
Buffalo 2
Chicago 2
Monmouth Junction 2
Pesaro 2
Portland 2
Scafati 2
Shenzhen 2
Tokyo 2
Verona 2
Zanjan 2
Andover 1
Ardabil 1
Auburn Hills 1
Augusta 1
Baotou 1
Brooklyn 1
Bucharest 1
Buti 1
Canberra 1
Castelfidardo 1
Changchun 1
Chengdu 1
Chongqing 1
Fayetteville 1
Foshan 1
Gunzenhausen 1
Haikou 1
Hanoi 1
Heze 1
Indiana 1
Islington 1
Totale 1.795
Nome #
Hyperphagic effect of novel compounds with high affinity for imidazoline I2 binding sites 234
Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functions 183
2-(2-Phenylcyclopropyl)imidazolines: Reversed Enantioselective Interaction at I1 and I2 Imidazoline Receptors 153
Imidazoline binding sites (IBS) profile modulation: Key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues 141
alpha(2)-Adrenoreceptors profile modulation. 2. Biphenyline analogues as tools for selective activation of the alpha2C-subtype 138
Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine 135
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes 123
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 122
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 112
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models 111
Alpha(2)-Adrenoreceptors Profile Modulation. 3. (R)-(+)-m-Nitrobiphenyline, a New Efficient and alpha(2C)-Subtype Selective Agonist. 109
alpha(2)-adrenoreceptors profile modulation. 4. From antagonist, to agonist behavior 105
Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4 chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation 105
Design, synthesis and muscarinic activity of deoxamuscarine-related derivatives 101
Alpha(2)-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 100
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 100
Agonists and antagonists targeting the different alpha(2)-adrenoceptor subtypes 92
Pharmacophore development and 3D-QSAR study of I1 imidazoline binding site ligands 92
Rational design of new alpha(2)-adrenoreceptor agonists 87
Binding of Tracizolines to the Imidazoline Receptor. Role of Lipophilicity in Quantitative Structure-Activity Relationship Models. 83
Structure-activity relationship at alpha-adrenergic receptors within a series of imidazoline analogues of cirazoline 80
Totale 2.506
Categoria #
all - tutte 9.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020513 73 21 48 82 24 69 45 59 26 32 9 25
2020/2021316 23 22 39 26 7 21 32 6 27 6 73 34
2021/2022230 16 45 0 23 21 16 11 18 15 24 14 27
2022/2023387 37 12 26 63 52 49 1 23 77 21 13 13
2023/2024214 26 12 14 4 7 8 5 10 26 5 4 93
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 2.506